Minimum 6 boxes added to cart with purchase order from distributor (orders placed in increments of 6).
The Accula System from Thermo Fisher Scientific the gold-standard rapid diagnostic platform that combines the accuracy of RT_PCR with the simplicity, convenience, and procedural familiarity of traditional rapid immunoassays. The Accula SARS-CoV-2 dock has received and Emergency Use Authorization(EUA) from the FDA for the detection of SARS-CoV-2 in Clinical Laboratory improvement Amendments(CLIA)- Waived environments.
Features and Benefits
Rapid Testing Results
RT-PCR SARS-CoV-2 results in 30 minutes
Streamlined Process
CLIA-waived workflow
Simplified sample collection
Nasal swabs and nasal mid-turbinate swabs
Trusted partner to health care providers
use of system helps prevent transmission during medical procedures and helps protect immuno-compromised patients
Easy
Store at room temperature, no need for refrigeration
Accurate results
100% positive and negative percent agreement (PPA and NPA) in prospective clinical study
